Italfarmaco and VeriSIM Life Partner to Develop Novel HDAC-Targeted Therapies

Strategic collaboration combines Italfarmaco’s leadership in HDAC biology and therapeutic development with VeriSIM Life’s Mechanistic AI dr...

October 07, 2026 | Wednesday | News
Piramal Pharma Solutions Opens New Microbiology Laboratory at Kentucky Sterile Injectables Facility

The new microbiology laboratory and sterility testing suite are designed for GMP drug product applications. This addition is part of the broader Lexingt...

October 07, 2026 | Wednesday | News
AnnJi Advances AJ201 into Phase 3 Trial for Kennedy’s Disease

AJ201 (rosolutamide) is an investigational oral small molecule designed to address multiple disease mechanisms of spinal and bulbar muscular atrophy (SBM...

October 06, 2026 | Tuesday | News
Agenus Reports Three-Year Survival Data for BOT+BAL in Recurrent Ovarian Cancer

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, announced three-year follow-up results from the ovarian cancer cohort of its 400+ patie...

October 06, 2026 | Tuesday | News
Lonza and Asimov Partner to Advance Lentiviral Vector Manufacturing for In Vivo Therapies

Collaboration connects Asimov’s genetic design and cell line technologies with Lonza’s process development, scale-up and GMP manufacturin...

October 05, 2026 | Monday | News
Mironid Doses First Patients in Phase 1 Trial of LoAc® Therapy for ADPKD

Phase 1 study is evaluating the safety, tolerability and pharmacokinetics of Mironid’s lead LoAc® small molecule in healthy volunteers Dosing ...

October 02, 2026 | Friday | News
Rakovina Therapeutics and Celvion Partner to Advance AI-Driven Precision Cancer Therapies

Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (OTCMKTS: RKVTF) a biopharmaceutical company advancing innovative cancer therapies through AI-powered d...

October 02, 2026 | Friday | News
Genentech’s Fenebrutinib Receives FDA Priority Review for Relapsing and Progressive Multiple Sclerosis

Fenebrutinib cut relapses by 51% and 58% vs teriflunomide in Phase III RMS trials (FENhance 1 & 2) while showing a consistent, positive trend in dela...

October 01, 2026 | Thursday | News
Vanda Reports Positive Phase III Results for HETLIOZ in Delayed Sleep-Wake Phase Disorder

Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) announced positive topline results from its pivotal Phase III study of HETLIOZ® (tasimelteon) 20 mg in a...

October 01, 2026 | Thursday | News
Terumo Neuro to Acquire Arsenal Medical to Expand Liquid Embolic Portfolio

Terumo Neuro announced that it has signed an agreement to acquire Arsenal Medical Inc., a privately held, clinical-stage biomaterials company developing Ne...

October 01, 2026 | Thursday | News
Verdiva Bio Presents VRB-103 Oral Amylin Data for Obesity Treatment

Verdiva Bio Limited (“Verdiva Bio” or “the Company”), a clinical-stage biotechnology company advancing the development of a portfol...

September 30, 2026 | Wednesday | News
Innovent Reports Phase 1 Data for IBI3003 Trispecific Antibody in Multiple Myeloma

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercializat...

September 30, 2026 | Wednesday | News
Caspian Therapeutics Reports KO-7246 Data in Type 1 and Type 2 Diabetes

– KO-7246 regenerated functional β-cell mass and produced durable glycemic control in Type 1 and Type 2 diabetes models – – KO-7246...

September 30, 2026 | Wednesday | News
Accuray and Samsung NeuroLogica Advance Volumetric Imaging for CyberKnife Platform

Accuray Incorporated (NASDAQ: ARAY) announced that it had entered into agreements with Samsung HME America, Inc., dba NeuroLogica Corp. ("Samsung NeuroLogi...

September 29, 2026 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close